Anion gap high is a condition that occurs when the levels of certain electrolytes in the bloodstream are out of balance. It is a common laboratory finding that can be indicative of a variety of underlying metabolic abnormalities. Anion gap high is also known as hyperchloremic metabolic acidosis or hyperchloremic acidosis. In this article, we will take a closer look at the link between metabolic abnormalities and anion gap elevations, and discuss the various causes of anion gap high.
An anion gap is a measure of the difference between the concentrations of certain electrolytes in the bloodstream. It is calculated by subtracting the concentrations of the major anions (chloride and bicarbonate) from the concentrations of the major cations (sodium and potassium). A normal anion gap is typically between 8 and 12 mmol/L. An elevated anion gap indicates that there is an imbalance between the concentrations of electrolytes in the blood.
Anion gap high can be caused by a variety of metabolic abnormalities. These abnormalities can be divided into three main categories: renal tubular acidosis, metabolic acidosis, and hyperchloremic acidosis.
Renal tubular acidosis (RTA) is a condition in which the kidneys are unable to excrete acid properly. This leads to an accumulation of acid in the bloodstream, which can cause anion gap high. RTA can be caused by a variety of conditions, including certain medications, chronic kidney disease, and inherited genetic disorders.
Metabolic acidosis is a condition in which the body produces too much acid, or is unable to effectively eliminate acid from the bloodstream. This can lead to anion gap high. Metabolic acidosis can be caused by a variety of underlying conditions, including diabetes, liver disease, and kidney failure.
Hyperchloremic acidosis is a condition in which the body produces too much chloride, or is unable to effectively eliminate chloride from the bloodstream. This can lead to anion gap high. Hyperchloremic acidosis can be caused by a variety of underlying conditions, including dehydration, certain medications, and certain medical procedures.
Anion gap high can be indicative of a variety of underlying conditions, and it is important for healthcare providers to be aware of the potential causes of anion gap high. An elevated anion gap can be a sign of metabolic acidosis, which can lead to a variety of serious complications, including kidney failure and coma. It is also important to note that anion gap high can be caused by a variety of conditions, and it is important to identify the underlying cause of the elevation in order to provide the most effective treatment.
Anion gap high is a common laboratory finding that can be indicative of a variety of underlying metabolic abnormalities. These abnormalities can be divided into three main categories: renal tubular acidosis, metabolic acidosis, and hyperchloremic acidosis. It is important for healthcare providers to be aware of the potential causes of anion gap high, as it can be indicative of a variety of serious conditions. Identifying the underlying cause of the elevation is essential in order to provide the most effective treatment.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation